The Relationship Between Osteoporosis and Phenotypic Heterogeneity in COPD

骨质疏松症与慢性阻塞性肺病表型异质性的关系

基本信息

  • 批准号:
    8519518
  • 负责人:
  • 金额:
    $ 13.03万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-08-01 至 2015-02-28
  • 项目状态:
    已结题

项目摘要

Program Director/Principal Investigator (Last, First, Middle): Bon, Jessica, Marie Project Summary Studies show an increased prevalence of osteoporosis in individuals with chronic obstructive pulmonary disease (COPD), yet an understanding of the true prevalence, clinical implications, and mechanistic relationships remains limited. This proposal will determine the prevalence of decreased bone mineral density (BMD) and accelerated loss of BMD over time and its relationship to markers of bone resorption and formation within spirometrically defined categories of obstruction severity in a large cohort of current and former smokers with wide variability of airflow limitation. Radiographic, clinical, and serum marker phenotypes will be used to construct a classification and prediction model to identify COPD patients at greatest risk for osteoporosis and accelerated loss of BMD over time. Finally, a set of translational experiments will compare osteoclast formation and activity and its relationship to serum inflammatory mediators in COPD patients with and without decreased BMD and accelerated loss of BMD over time. These aims will define the COPD phenotype that should undergo osteoporosis screening, provide insight into the underlying mechanisms relating COPD and osteoporosis, and identify possible targets for screening and therapy. Training Plan: This proposal will provide the candidate with the unique opportunity to cross medical disciplines, expanding her COPD knowledge-base while developing a background in osteoporosis and bone metabolism. Through coursework and conferences, the candidate will acquire advanced training in biostatistics, epidemiology, and bioinformatics. Techniques learned in Dr. Roodman's laboratory through implementation of this proposal will equip the candidate with the skills necessary to communicate effectively during translational collaborations. The resources and experience of mentor Dr. Sciurba, an expert in COPD clinical phenotyping and outcome assessment in clinical trials, and co-mentor Dr. Roodman, an authority on multiple myeloma and bone disease, combined with the robust research environment at the University of Pittsburgh, ensure the candidate's successful evolution to an independent investigator. RELEVANCE (See instructions): The increased prevalence of osteoporosis in patients with COPD likely has both clinical and functional consequences, contributing significantly to disease burden. Limited understanding of the true prevalence, clinical implications and mechanistic relationship of osteoporosis in COPD necessitates a more precise characterization of the of the COPD patient at risk for osteoporosis as well as further elucidation of the clinical and biologic factors linking the lung and skeletal systems.
项目总监/首席研究员(最后、第一、中间):Bon、Jessica、Marie 项目概要 研究表明,慢性阻塞性肺疾病患者骨质疏松症患病率增加 疾病(COPD),但了解真实的患病率、临床意义和机制 关系仍然有限。该提案将确定骨矿物质减少的患病率 密度(BMD)和 BMD 随着时间的推移加速损失及其与骨吸收和骨吸收标志物的关系 在大量当前和 以前吸烟者的气流受限变化很大。放射学、临床和血清标志物 表型将用于构建分类和预测模型,以识别 COPD 患者 随着时间的推移,骨质疏松症和骨密度加速损失的风险最大。最后附上一组翻译 实验将比较破骨细胞的形成和活性及其与血清炎症的关系 随着时间的推移,慢性阻塞性肺病 (COPD) 患者的 BMD 是否下降以及 BMD 加速损失。 这些目标将定义应进行骨质疏松症筛查的慢性阻塞性肺病表型,提供见解 深入了解慢性阻塞性肺病和骨质疏松症的相关机制,并确定可能的筛查目标 和治疗。培训计划:该提案将为候选人提供独特的跨界机会 医学学科,扩大她的慢性阻塞性肺病知识库,同时发展骨质疏松症的背景 和骨代谢。通过课程和会议,候选人将获得高级培训 生物统计学、流行病学和生物信息学。在鲁德曼博士的实验室中通过以下方式学到的技术 该提案的实施将使候选人具备有效沟通所需的技能 在翻译合作期间。导师COPD专家Sciurba博士的资源和经验 临床试验中的临床表型和结果评估,以及联合导师 Roodman 博士,他是该领域的权威 多发性骨髓瘤和骨病,结合大学强大的研究环境 匹兹堡,确保候选人成功转型为独立调查员。 相关性(参见说明): 慢性阻塞性肺病 (COPD) 患者骨质疏松患病率的增加可能具有临床和功能方面的影响 后果,显着加重疾病负担。对真实患病率的了解有限, COPD 中骨质疏松的临床意义和机制关系需要更精确的研究 具有骨质疏松风险的 COPD 患者的特征以及进一步阐明 连接肺和骨骼系统的临床和生物学因素。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Does radiographic emphysema correlate with low bone mineral density?
放射线检查肺气肿与骨密度低是否相关?
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JESSICA BON其他文献

JESSICA BON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JESSICA BON', 18)}}的其他基金

Fungal Translocation in Chronic Obstructive Pulmonary Disease
慢性阻塞性肺疾病中的真菌移位
  • 批准号:
    10610446
  • 财政年份:
    2022
  • 资助金额:
    $ 13.03万
  • 项目类别:
Fungal Translocation in Chronic Obstructive Pulmonary Disease
慢性阻塞性肺疾病中的真菌移位
  • 批准号:
    10434243
  • 财政年份:
    2022
  • 资助金额:
    $ 13.03万
  • 项目类别:
Pittsburgh Innovation in Collaborative Training of Residents Alliance
匹兹堡居民联盟协作培训创新
  • 批准号:
    10608088
  • 财政年份:
    2020
  • 资助金额:
    $ 13.03万
  • 项目类别:
Pittsburgh Innovation in Collaborative Training of Residents Alliance
匹兹堡居民联盟协作培训创新
  • 批准号:
    10350563
  • 财政年份:
    2020
  • 资助金额:
    $ 13.03万
  • 项目类别:
The impact of a home-based pulmonary telerehabilitation program on muscle function and quality of life following acute exacerbations of chronic obstructive pulmonary disease
家庭肺远程康复计划对慢性阻塞性肺疾病急性加重后肌肉功能和生活质量的影响
  • 批准号:
    10201778
  • 财政年份:
    2019
  • 资助金额:
    $ 13.03万
  • 项目类别:
Autoimmunity and emphysema and risk of osteoporosis in smokers
吸烟者的自身免疫和肺气肿以及骨质疏松症的风险
  • 批准号:
    9916794
  • 财政年份:
    2016
  • 资助金额:
    $ 13.03万
  • 项目类别:
Emphysema and Inflammatory Biomarkers and Risk of Osteoporosis in Men with COPD
肺气肿和炎症生物标志物以及男性慢性阻塞性肺病患者骨质疏松症的风险
  • 批准号:
    9551566
  • 财政年份:
    2015
  • 资助金额:
    $ 13.03万
  • 项目类别:
Emphysema and Inflammatory Biomarkers and Risk of Osteoporosis in Men with COPD
肺气肿和炎症生物标志物以及男性慢性阻塞性肺病患者骨质疏松症的风险
  • 批准号:
    9932924
  • 财政年份:
    2015
  • 资助金额:
    $ 13.03万
  • 项目类别:
Emphysema and Inflammatory Biomarkers and Risk of Osteoporosis in Men with COPD
肺气肿和炎症生物标志物以及男性慢性阻塞性肺病患者骨质疏松症的风险
  • 批准号:
    9337253
  • 财政年份:
    2015
  • 资助金额:
    $ 13.03万
  • 项目类别:
The Relationship Between Osteoporosis and Phenotypic Heterogeneity in COPD
骨质疏松症与慢性阻塞性肺病表型异质性的关系
  • 批准号:
    7903213
  • 财政年份:
    2009
  • 资助金额:
    $ 13.03万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 13.03万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 13.03万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 13.03万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.03万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 13.03万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 13.03万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 13.03万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 13.03万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 13.03万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 13.03万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了